title: Anxiety in patients with cancer and human immunodeficiency virus.
abstract: Physicians who treat patients with cancer or human immunodeficiency virus (HIV) infections frequently encounter the psychological and physical manifestations of anxiety in these populations. This chapter provides a review of the prevalence of anxiety disorders in cancer and HIV patients. The problems in assessment and diagnosis of anxiety in these patients are discussed, and a literature review of the types of anxiety disorders commonly identified in the context of cancer and HIV/AIDS is presented. Finally, the treatment of anxiety in cancer and HIV patients utilizing both pharmacologic and nonpharmacologic modalities is reviewed.
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
authors.forename: T
authors.initials: T
authors.lastname: Kerrihard
authors.forename: W
authors.initials: W
authors.lastname: Breitbart
authors.forename: R
authors.initials: R
authors.lastname: Dent
authors.forename: D
authors.initials: D
authors.lastname: Strout
mesh_terms: D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001007:Anxiety / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D001008:Anxiety Disorders / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D003937:Diagnosis, Differential; D015658:HIV Infections / Q000523:psychology*; D006801:Humans; D009369:Neoplasms / Q000523:psychology*; D015995:Prevalence; D013315:Stress, Psychological / Q000209:etiology
chemical_list: D014151:Anti-Anxiety Agents